Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/10/21 → 7/10/26 |
Keywords
- Crohn’s Disease
- treatment safety
- treatment efficacy
- phase 3 study
Clinical Trial Phase
- Phase III (a & b)
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Crohn’s Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
- Moore, Gregory (Primary Chief Investigator (PCI))
Project: Research